QIAGEN CLC LightSpeed Module delivers an ultra-fast, end-to-end hereditary NGS FASTQ to VCF pipeline. LightSpeed takes raw FASTQ files generated by paired-end 150 bp sequencing protocols and performs quality trimming, […]
In this training, we will focus on how you can use QIAGEN Omicsoft Studio and QIAGEN Ingenuity Pathway Analysis (IPA) to discover new biomarkers, validate (or study) drug targets and […]
We are excited to bring thought leaders, NGS experts, lab directors, variant scientists, clinicians, and oncologists under one virtual roof at our second annual Clinical Oncology Summit hosted on April […]
You may not have a typical transcriptomics dataset (i.e., a list of genes with differential expression), yet, you’d like to analyze a list of IDs. In this training, we will […]
We are excited to bring thought leaders, NGS experts, lab directors, variant scientists, clinicians, and oncologists under one virtual roof at our second annual Clinical Oncology Summit hosted on April […]
In this 90-minute training session, you will learn how to identify target mRNAs for your miRNAs of interest and associate them with pathways, diseases, biological functions, tissues and cell types. […]
Dentro de las aplicaciones oncológicas, la capacidad de identificar alteraciones genéticas potencialmente accionables y explorar las vulnerabilidades moleculares del cáncer es cada vez más difícil. Una nueva base de datos […]
In 2023, we want to hear stories of improved communication and bridging gaps. Of technology used to harness the power of agility. Of process improvements, impediments removal and common goals. About […]
If you're a data scientist or bioinformatician working in biopharma, here's your chance to explore an advanced and comprehensive way to access and analyze high-quality 'omics data. The QIAGEN OmicSoft […]
Get a first-hand look at QIAGEN’s new Sample to Insight Hereditary solution. By attending this webinar, you will: Learn more about each workflow component. Hear from experts in the field as they discuss how this technology advances the diagnosis and management of inherited diseases. Examine real-world case studies demonstrating the clinical utility and cost-effectiveness of […]
You asked for it by popular demand, and we’re here to deliver. In this training, we’ll cover how antimicrobial resistance (AMR) is used for isolation or can be easily integrated with other functionalities such as multi-locus sequence typing (MLST). In this training, we’ll cover: • Introduction to AMR, MLST and relevant databases • QIAGEN Microbial […]
Learn about our Sample to Insight solutions for inherited disorders This year at the European Society for Human Genetics (ESHG) 2023 Annual Meeting, QIAGEN will be at booth #472 premiering our new barrier-breaking Sample to Insight workflow for inherited disease NGS testing—a fast, cheap, ultra-precise panel to report pipeline. Learn more about our products and solutions […]
Industry leaders discuss how to improve the speed, precision and cost-effectiveness of clinical exome testing for newborn screening and rare and undiagnosed diseases Clinical exome testing is revolutionizing the diagnosis of rare and inherited diseases. Its ability to quickly pinpoint the genetic causes of complex conditions has made it a critical component of personalized medicine, […]
Watch NowIn this training, you will learn how to analyze viral samples using QIAGEN CLC Genomics Workbench. This webinar will focus on bioinformatics workflows and data interpretation using H5N1 as an example, but similar analysis can be done with other viral and microbial (bacteria, fungus and more) samples. Using viral samples, you will learn how to: […]
Watch NowMore and more biopharma and academic groups are looking to process a large number of samples simultaneously or for a quicker turnaround time. This webinar will introduce a flexible and powerful setup for running your NGS sequence analyses through servers or Amazon Web Services (AWS), depending on user preference. We will demonstrate how CLC Genomics […]
Watch NowThere is a strong interest in the scientific community to use public (GEO, SRA, TCGA, LINCS, etc.) omics (RNA-seq, scRNA-seq, microarray, proteomics, etc.) data for a variety of discoveries. This webinar, aimed at data scientists, bioinformaticians and similar roles in biopharma and academia, explores a comprehensive way of accessing and analyzing high-quality, expertly curated omics […]
Watch NowYou’re invited to attend the 2024 Clinician’s Roundtable, a virtual event where medical directors and oncologists will discuss how to better interpret genomic test results to tailor treatment strategies for cancer patients. As the role of the Molecular Tumor Board (MTB) becomes increasingly important in the implementation of evidence-based precision cancer medicine programs, molecular pathology […]
Watch NowIngenuity Pathway Analysis (IPA), currently cited in tens of thousands of publications and used by a large number of biopharmaceutical companies, is backed by QIAGEN Biomedical KB-HD. Accordingly, biomedical relationships knowledge has practically become required for innovative data- and analytics-driven drug discovery. It powers biomedical knowledge graph analysis, artificial intelligence (AI)-driven target identification and many […]
Watch Now
